Crossmark

Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy

Published Online: 2021-01-27

Published Print: 2021-03

Authors

Liu, Zhiyu

Li, Yang

Shi, Ce https://orcid.org/0000-0003-0235-8164
License Information

Text and Data Mining valid from 2021-01-27

Version of Record valid from 2021-01-27
More Information

Article History

Received: 15 October 2020

Revised: 12 January 2021

Accepted: 13 January 2021

First Online: 27 January 2021

Compliance with ethical standards

:

: The authors declare that there are no conflicts of interest in this work.

Document is current